feed,title,long_url,short_url
SeekingAlpha,Alnylam amyloidosis drug led to “small” benefits in Phase 3 trial: FDA,https://seekingalpha.com/news/4010608,
SeekingAlpha,CME to launch options on micro gold futures to meet growing demand,https://seekingalpha.com/news/4010607,
SeekingAlpha,Mirum Pharmaceuticals appointed Eric Bjerkholt as CFO,https://seekingalpha.com/news/4010606,
